5:2 intermittent fasting halts liver cancer and inflammation development in mice with pre-existing liver inflammation, per German Cancer Research Center and University of Tübingen study.
Intermittent fasting using a 5:2 schedule can halt the development of liver cancer and liver inflammation in mice with pre-existing liver inflammation, according to research by scientists from the German Cancer Research Center and the University of Tübingen. The study identified two proteins in liver cells that are jointly responsible for the protective effect of fasting, and an approved drug can partially mimic this effect.
May 07, 2024
3 Articles